Keefe Bruyette re-initiated coverage of Corebridge (CRBG) with an Outperform rating and $32 price target The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge Advances Governance Independence as AIG Influence Fades
- Corebridge Announces Upcoming Nippon-Designated Board Member Change
- Corebridge price target lowered to $33 from $34 at Barclays
- Corebridge price target lowered to $35 from $38 at TD Cowen
- Corebridge price target lowered to $32 from $35 at Morgan Stanley
